Citation Impact
Citing Papers
Informational Paper: Drug‐Associated Gingival Enlargement
2004
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials*
2006
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
PHOENIX
2011
Classification and Grading of Gastritis
1996 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant
2008
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
2009
Fungal infections in the recipients of solid organ transplantation
2003
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality
1998
Spontaneous bacterial peritonitis: recent guidelines and beyond
2011
Antifungal Agents. Part II. The Azoles
1999
Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation
2008
Candida in Solid Organ Transplant Recipients
2009
Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients
2006
Anandamide – the other side of the coin
2000 StandoutNobel
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Outcomes of antifungal prophylaxis in high‐risk liver transplant recipients
2008
Fungal infections in solid organ transplantation
2007
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis
2006
Update on antifungal treatment of invasive Candida and Aspergillus infections
2004
Invasive Aspergillosis in Transplant Recipients
1999
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement
2003
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
2002
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Bench-to-bedside review: Candida infections in the intensive care unit
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study
2003
Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study
2006
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Prevention of infections in solid organ transplant recipients
1999
Pulmonary vascular disorders in portal hypertension
1998
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Severe sepsis in cirrhosis†
2009
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
2001
Periodontal diseases
2005 Standout
Antifungal prophylaxis in liver transplant recipients
2009
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis
1995
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections
2000
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients
2010
Spontaneous bacterial empyema in cirrhotic patients: A prospective study
1996
Infection in Solid-Organ Transplant Recipients
2007 Standout
Peptidergic sensory neurons in the control of vascular functions: Mechanisms and significance in the cutaneous and splanchnic vascular beds
2005
High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients
2011
Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites
2000
Replication of hepatitis C virus
2007 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Zygomycetes in Human Disease
2000 Standout
The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit
2010 StandoutNobel
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience
2005
Effectiveness of Periodontal Therapy in Patients With Drug‐Induced Gingival Overgrowth. Long‐Term Results
1999
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Invasive Candidiasis
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Antifungal agents for preventing fungal infections in solid organ transplant recipients
2004
Ascitic fluid pH and lactate: Insensitive and nonspecific tests in detecting ascitic fluid infection
1991
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Prophylactic Fluconazole in Liver Transplant Recipients
1999
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Pleural Effusion
2002 Standout
Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1
2002
Prosthetic Joint Infection
2014 Standout
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Physiological roles and properties of potassium channels in arterial smooth muscle
1995 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
SPONTANEOUS BACTERIAL PERITONITIS
1992
Works of C. Barrios being referenced
Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation
1996
Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients
1997
Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis
1990
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
2006
Enhanced endothelium-dependent vasodilation in patients with cirrhosis
1995
Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.
1993
Study of the secretion of pepsinogen I in cirrhotic humans with and without portacaval shunt.
1988